Evaluation of Dissolution Media Containing a Novel Synthetic Surfactant by In Vitro Testing of BCS Class II Drugs

被引:5
|
作者
Jogia, Hitesh [1 ,2 ]
Mehta, Tushar [2 ]
Patel, Madhabhai [1 ]
机构
[1] Kalol Inst Pharm, Kalol 382711, Gujarat, India
[2] Torrent Pharmaceut Ltd, Torrent Res Ctr, Analyt Dev Lab, Bhat 382428, Gujarat, India
来源
DISSOLUTION TECHNOLOGIES | 2009年 / 16卷 / 03期
关键词
VIVO PERFORMANCE; SOLUBILITY; ABSORPTION; PROFILE;
D O I
10.14227/DT160309P14
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The objective of this study was to employ a tailor-made, surface-active agent (phosphonobile acid) in the design of dissolution media that more closely reflect various luminal fluid physicochemical parameters such as buffer capacity, osmolarity, surface tension, and pH. The proposed media are simple to prepare and use, and thus can be explored for routine application. Three BCS II drugs, glimepiride, dipyridamole, and ibuprofen, were selected for the study. In vitro dissolution profiles obtained with the proposed media were compared with profiles obtained in FaSSIF and FeSSIF media using the f(2) similarity factor. Dissolution in the proposed media correlate well with the dissolution obtained in FaSSIF and FeSSIF media.
引用
收藏
页码:14 / 19
页数:6
相关论文
共 49 条
  • [1] Evaluation of In Vitro Equivalence for Drugs Containing BCS Class II Compound Ketoprofen
    Shohin, I. E.
    Kulinich, J. I.
    Ramenskaya, G. V.
    Vasilenko, G. F.
    DISSOLUTION TECHNOLOGIES, 2011, 18 (01): : 26 - 29
  • [2] Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs
    Lehto, Paula
    Kortejarvi, Hanna
    Liimatainen, Anni
    Ojala, Krista
    Kangas, Heli
    Hirvonen, Jouni
    Tanninen, Veli Pekka
    Peltonen, Leena
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 78 (03) : 531 - 538
  • [3] Comparison of statistical analysis and Bayesian networks in the evaluation of dissolution performance of BCS class II model drugs
    Wilson, WI
    Peng, Y
    Augsburger, LL
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (12) : 2764 - 2776
  • [4] Development and Validation of In Vitro Discriminatory Dissolution Testing Method for Fast Dispersible Tablets of BCS Class II Drug
    Bhatt, Shailendra
    Roy, Dabashis
    Kumar, Manish
    Saharan, Renu
    Malik, Anuj
    Saini, Vipin
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 17 (01) : 74 - 80
  • [5] Effect of Gastric Fluid Volume on the In Vitro Dissolution and In Vivo Absorption of BCS Class II Drugs: a Case Study with Nifedipine
    Ahmed M. Nader
    Sara K. Quinney
    Hala M. Fadda
    David R. Foster
    The AAPS Journal, 2016, 18 : 981 - 988
  • [6] Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs
    E. Galia
    E. Nicolaides
    D. Hörter
    R. Löbenberg
    C. Reppas
    J. B. Dressman
    Pharmaceutical Research, 1998, 15 : 698 - 705
  • [7] Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs
    Galia, E
    Nicolaides, E
    Hörter, D
    Löbenberg, R
    Reppas, C
    Dressman, JB
    PHARMACEUTICAL RESEARCH, 1998, 15 (05) : 698 - 705
  • [8] Effect of Gastric Fluid Volume on the In Vitro Dissolution and In Vivo Absorption of BCS Class II Drugs: a Case Study with Nifedipine
    Nader, Ahmed M.
    Quinney, Sara K.
    Fadda, Hala M.
    Foster, David R.
    AAPS JOURNAL, 2016, 18 (04): : 981 - 988
  • [9] Insight into the Development of Dissolution Media for BCS Class II Drugs: A Review from Quality Control and Prediction of In Vivo Performance Perspectives
    Wu, Chunnuan
    Liu, Yan
    He, Zhonggui
    Sun, Jin
    CURRENT DRUG DELIVERY, 2016, 13 (07) : 1004 - 1020
  • [10] Dissolution media for in vitro testing of water-insoluble drugs: Effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate
    Crison, JR
    Weiner, ND
    Amidon, GL
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (03) : 384 - 388